Concern over blood clots in a small number of patients who have received the Oxford/AstraZeneca vaccine have led to a number of countries suspending its use. But out of 20 million people who were vaccinated against coronavirus by the end of March in the UK, only 79 people had blood clots, and 19 people died.… Read More »
While the matter is investigated more thoroughly, the MHRA hold the stance that current evidence “does not confirm that the vaccine is the cause” of the blood clot. So what are the official side effects of the jab? Appearing on BBC One today, Dr Sarah Jarvis said: “People have blood clots all the time.” Discussing… Read More »
AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people worldwide and 30,000 in the US as company signs £15million manufacturing deal Thousands volunteers already being injected with jab in UK, Brazil, South Africa Preliminary data from phase 3 trials expected ‘soon’, said lead jab researcher Developers say they hope to deliver the… Read More »
Last week, Western intelligence officials pegged Russian hackers with an attempt to rip off leading research for a COVID-19 vaccine, linking the would-be thieves with the country’s intelligence services. Russia itself denies involvement in any of those attacks—and with a new licensing deal for AstraZeneca’s COVID-19 shot, the country says it doesn’t need the secrets… Read More »
The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »